nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—HTR1B—hypertension	0.124	0.515	CbGaD
Ondansetron—CYP3A5—hypertension	0.117	0.485	CbGaD
Ondansetron—HTR1B—Pindolol—hypertension	0.0188	0.0399	CbGbCtD
Ondansetron—HTR1B—Penbutolol—hypertension	0.0153	0.0325	CbGbCtD
Ondansetron—KCNH2—Terazosin—hypertension	0.015	0.0318	CbGbCtD
Ondansetron—HTR1A—Nebivolol—hypertension	0.0138	0.0294	CbGbCtD
Ondansetron—KCNH2—Doxazosin—hypertension	0.0125	0.0265	CbGbCtD
Ondansetron—HTR1A—Pindolol—hypertension	0.0118	0.025	CbGbCtD
Ondansetron—KCNH2—Bepridil—hypertension	0.0107	0.0228	CbGbCtD
Ondansetron—KCNH2—Prazosin—hypertension	0.0102	0.0218	CbGbCtD
Ondansetron—HTR1B—Propranolol—hypertension	0.00961	0.0204	CbGbCtD
Ondansetron—HTR1A—Penbutolol—hypertension	0.00959	0.0204	CbGbCtD
Ondansetron—KCNH2—Carvedilol—hypertension	0.00885	0.0188	CbGbCtD
Ondansetron—HTR3A—area postrema—hypertension	0.00785	0.231	CbGeAlD
Ondansetron—HTR1A—Prazosin—hypertension	0.00758	0.0161	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Nisoldipine—hypertension	0.00638	0.0136	CbGbCtD
Ondansetron—CYP3A7—Nisoldipine—hypertension	0.00638	0.0136	CbGbCtD
Ondansetron—CYP3A7—Diltiazem—hypertension	0.00616	0.0131	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Diltiazem—hypertension	0.00616	0.0131	CbGbCtD
Ondansetron—CYP3A7—Eplerenone—hypertension	0.00616	0.0131	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Eplerenone—hypertension	0.00616	0.0131	CbGbCtD
Ondansetron—HTR1A—Propranolol—hypertension	0.00602	0.0128	CbGbCtD
Ondansetron—KCNH2—Verapamil—hypertension	0.00559	0.0119	CbGbCtD
Ondansetron—CYP3A5—Reserpine—hypertension	0.00544	0.0116	CbGbCtD
Ondansetron—CYP2C9—Eprosartan—hypertension	0.0054	0.0115	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Amlodipine—hypertension	0.00493	0.0105	CbGbCtD
Ondansetron—CYP3A7—Amlodipine—hypertension	0.00493	0.0105	CbGbCtD
Ondansetron—CYP1A2—Guanabenz—hypertension	0.00488	0.0104	CbGbCtD
Ondansetron—CYP1A2—Triamterene—hypertension	0.00488	0.0104	CbGbCtD
Ondansetron—CYP3A5—Nisoldipine—hypertension	0.00479	0.0102	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Felodipine—hypertension	0.00475	0.0101	CbGbCtD
Ondansetron—CYP3A7—Felodipine—hypertension	0.00475	0.0101	CbGbCtD
Ondansetron—CYP3A5—Diltiazem—hypertension	0.00462	0.00983	CbGbCtD
Ondansetron—CYP3A5—Eplerenone—hypertension	0.00462	0.00983	CbGbCtD
Ondansetron—CYP3A7—Nifedipine—hypertension	0.0046	0.00977	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Nifedipine—hypertension	0.0046	0.00977	CbGbCtD
Ondansetron—CYP2E1—Nifedipine—hypertension	0.00444	0.00943	CbGbCtD
Ondansetron—CYP2C9—Torasemide—hypertension	0.0044	0.00935	CbGbCtD
Ondansetron—CYP2D6—Labetalol—hypertension	0.0044	0.00935	CbGbCtD
Ondansetron—CYP2D6—Nebivolol—hypertension	0.0044	0.00935	CbGbCtD
Ondansetron—CYP2E1—Carvedilol—hypertension	0.00437	0.00928	CbGbCtD
Ondansetron—CYP2E1—Nicardipine—hypertension	0.00437	0.00928	CbGbCtD
Ondansetron—CYP3A7—Propranolol—hypertension	0.00416	0.00885	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Propranolol—hypertension	0.00416	0.00885	CbGbCtD
Ondansetron—CYP2C9—Candesartan—hypertension	0.00409	0.00869	CbGbCtD
Ondansetron—CYP2C9—Guanfacine—hypertension	0.00409	0.00869	CbGbCtD
Ondansetron—CYP1A2—Betaxolol—hypertension	0.00405	0.0086	CbGbCtD
Ondansetron—CYP2D6—Acebutolol—hypertension	0.00402	0.00855	CbGbCtD
Ondansetron—CYP2D6—Metoprolol—hypertension	0.00374	0.00795	CbGbCtD
Ondansetron—CYP2D6—Pindolol—hypertension	0.00374	0.00795	CbGbCtD
Ondansetron—CYP3A5—Amlodipine—hypertension	0.0037	0.00785	CbGbCtD
Ondansetron—CYP3A4—Guanethidine—hypertension	0.00369	0.00785	CbGbCtD
Ondansetron—CYP3A5—Felodipine—hypertension	0.00356	0.00757	CbGbCtD
Ondansetron—CYP1A2—Nisoldipine—hypertension	0.00356	0.00757	CbGbCtD
Ondansetron—CYP3A7—Atorvastatin—hypertension	0.00354	0.00752	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Atorvastatin—hypertension	0.00354	0.00752	CbGbCtD
Ondansetron—CYP3A5—Nifedipine—hypertension	0.00345	0.00733	CbGbCtD
Ondansetron—CYP3A5—Nicardipine—hypertension	0.00339	0.00721	CbGbCtD
Ondansetron—CYP2D6—Betaxolol—hypertension	0.00333	0.00709	CbGbCtD
Ondansetron—CYP3A5—Propranolol—hypertension	0.00312	0.00664	CbGbCtD
Ondansetron—CYP2C9—Diltiazem—hypertension	0.0031	0.00659	CbGbCtD
Ondansetron—CYP3A5—Clonidine—hypertension	0.00298	0.00633	CbGbCtD
Ondansetron—CYP2D6—Doxazosin—hypertension	0.00294	0.00624	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Verapamil—hypertension	0.00286	0.00607	CbGbCtD
Ondansetron—CYP3A7—Verapamil—hypertension	0.00286	0.00607	CbGbCtD
Ondansetron—CYP2C9—Valsartan—hypertension	0.00284	0.00603	CbGbCtD
Ondansetron—CYP2D6—Diltiazem—hypertension	0.00284	0.00603	CbGbCtD
Ondansetron—CYP1A2—Irbesartan—hypertension	0.00281	0.00596	CbGbCtD
Ondansetron—CYP3A4—Hydralazine—hypertension	0.0028	0.00595	CbGbCtD
Ondansetron—CYP1A2—Amlodipine—hypertension	0.00275	0.00585	CbGbCtD
Ondansetron—CYP3A5—Atorvastatin—hypertension	0.00266	0.00564	CbGbCtD
Ondansetron—HTR3A—vagus nerve—hypertension	0.00262	0.077	CbGeAlD
Ondansetron—CYP1A2—Nifedipine—hypertension	0.00257	0.00545	CbGbCtD
Ondansetron—CYP2C9—Irbesartan—hypertension	0.00253	0.00537	CbGbCtD
Ondansetron—CYP2D6—Bepridil—hypertension	0.00253	0.00537	CbGbCtD
Ondansetron—CYP1A2—Carvedilol—hypertension	0.00253	0.00537	CbGbCtD
Ondansetron—CYP2C9—Amlodipine—hypertension	0.00248	0.00527	CbGbCtD
Ondansetron—CYP3A5—Losartan—hypertension	0.00243	0.00516	CbGbCtD
Ondansetron—CYP2C9—Felodipine—hypertension	0.00239	0.00508	CbGbCtD
Ondansetron—CYP3A4—Guanfacine—hypertension	0.00238	0.00506	CbGbCtD
Ondansetron—CYP1A2—Propranolol—hypertension	0.00232	0.00494	CbGbCtD
Ondansetron—CYP2C9—Nifedipine—hypertension	0.00231	0.00491	CbGbCtD
Ondansetron—CYP2D6—Irbesartan—hypertension	0.00231	0.00491	CbGbCtD
Ondansetron—CYP2C9—Nicardipine—hypertension	0.00228	0.00484	CbGbCtD
Ondansetron—CYP2C9—Carvedilol—hypertension	0.00228	0.00484	CbGbCtD
Ondansetron—CYP2D6—Amlodipine—hypertension	0.00227	0.00482	CbGbCtD
Ondansetron—CYP1A2—Clonidine—hypertension	0.00222	0.00471	CbGbCtD
Ondansetron—CYP2D6—Felodipine—hypertension	0.00219	0.00464	CbGbCtD
Ondansetron—CYP2D6—Timolol—hypertension	0.00215	0.00457	CbGbCtD
Ondansetron—CYP3A5—Verapamil—hypertension	0.00214	0.00456	CbGbCtD
Ondansetron—CYP3A4—Isradipine—hypertension	0.00212	0.00451	CbGbCtD
Ondansetron—CYP2D6—Nifedipine—hypertension	0.00211	0.00449	CbGbCtD
Ondansetron—CYP2D6—Carvedilol—hypertension	0.00208	0.00442	CbGbCtD
Ondansetron—CYP2D6—Nicardipine—hypertension	0.00208	0.00442	CbGbCtD
Ondansetron—CYP2D6—Propranolol—hypertension	0.00192	0.00407	CbGbCtD
Ondansetron—CYP2D6—Captopril—hypertension	0.00189	0.00402	CbGbCtD
Ondansetron—CYP3A4—Nisoldipine—hypertension	0.00187	0.00397	CbGbCtD
Ondansetron—CYP3A4—Indapamide—hypertension	0.00187	0.00397	CbGbCtD
Ondansetron—CYP2D6—Clonidine—hypertension	0.00183	0.00388	CbGbCtD
Ondansetron—CYP1A2—Losartan—hypertension	0.00181	0.00384	CbGbCtD
Ondansetron—CYP3A4—Diltiazem—hypertension	0.0018	0.00383	CbGbCtD
Ondansetron—CYP3A4—Eplerenone—hypertension	0.0018	0.00383	CbGbCtD
Ondansetron—CYP2C9—Atorvastatin—hypertension	0.00178	0.00378	CbGbCtD
Ondansetron—CYP2C9—Losartan—hypertension	0.00163	0.00346	CbGbCtD
Ondansetron—CYP2D6—Atorvastatin—hypertension	0.00163	0.00346	CbGbCtD
Ondansetron—CYP3A4—Enalapril—hypertension	0.00161	0.00341	CbGbCtD
Ondansetron—CYP1A2—Verapamil—hypertension	0.0016	0.00339	CbGbCtD
Ondansetron—CYP3A4—Irbesartan—hypertension	0.00147	0.00312	CbGbCtD
Ondansetron—HTR4—adrenal cortex—hypertension	0.00145	0.0427	CbGeAlD
Ondansetron—CYP3A4—Amlodipine—hypertension	0.00144	0.00306	CbGbCtD
Ondansetron—CYP2C9—Verapamil—hypertension	0.00144	0.00305	CbGbCtD
Ondansetron—CYP3A4—Felodipine—hypertension	0.00139	0.00295	CbGbCtD
Ondansetron—CYP3A4—Nifedipine—hypertension	0.00134	0.00286	CbGbCtD
Ondansetron—CYP3A4—Carvedilol—hypertension	0.00132	0.00281	CbGbCtD
Ondansetron—CYP3A4—Nicardipine—hypertension	0.00132	0.00281	CbGbCtD
Ondansetron—CYP2D6—Verapamil—hypertension	0.00131	0.00279	CbGbCtD
Ondansetron—CYP3A4—Propranolol—hypertension	0.00122	0.00259	CbGbCtD
Ondansetron—CYP3A4—Clonidine—hypertension	0.00116	0.00247	CbGbCtD
Ondansetron—HTR4—adrenal gland—hypertension	0.00105	0.0308	CbGeAlD
Ondansetron—CYP3A4—Atorvastatin—hypertension	0.00104	0.0022	CbGbCtD
Ondansetron—SLC47A2—kidney—hypertension	0.000983	0.0289	CbGeAlD
Ondansetron—SLC47A2—cortex of kidney—hypertension	0.000957	0.0282	CbGeAlD
Ondansetron—CYP3A4—Losartan—hypertension	0.000947	0.00201	CbGbCtD
Ondansetron—HTR1B—artery—hypertension	0.000864	0.0254	CbGeAlD
Ondansetron—CYP3A4—Verapamil—hypertension	0.000836	0.00178	CbGbCtD
Ondansetron—CYP1A2—urine—hypertension	0.000764	0.0225	CbGeAlD
Ondansetron—CYP2C9—urine—hypertension	0.000725	0.0213	CbGeAlD
Ondansetron—CYP2E1—urine—hypertension	0.000687	0.0202	CbGeAlD
Ondansetron—HTR1B—blood vessel—hypertension	0.000673	0.0198	CbGeAlD
Ondansetron—SLC47A2—central nervous system—hypertension	0.000621	0.0183	CbGeAlD
Ondansetron—CYP3A4—urine—hypertension	0.000553	0.0163	CbGeAlD
Ondansetron—CYP2D6—urine—hypertension	0.000544	0.016	CbGeAlD
Ondansetron—CYP3A7-CYP3A51P—nephron tubule—hypertension	0.000479	0.0141	CbGeAlD
Ondansetron—HTR3A—brainstem—hypertension	0.000438	0.0129	CbGeAlD
Ondansetron—SLC47A1—brainstem—hypertension	0.000431	0.0127	CbGeAlD
Ondansetron—CYP3A7-CYP3A51P—cortex of kidney—hypertension	0.00041	0.0121	CbGeAlD
Ondansetron—OPRM1—brainstem—hypertension	0.000402	0.0118	CbGeAlD
Ondansetron—SLC47A1—nephron tubule—hypertension	0.000391	0.0115	CbGeAlD
Ondansetron—SLC47A1—adrenal cortex—hypertension	0.000385	0.0113	CbGeAlD
Ondansetron—SLC47A1—heart—hypertension	0.000373	0.011	CbGeAlD
Ondansetron—HTR1B—brainstem—hypertension	0.000368	0.0108	CbGeAlD
Ondansetron—SLC47A1—decidua—hypertension	0.000362	0.0107	CbGeAlD
Ondansetron—KCNH2—cardiac ventricle—hypertension	0.000348	0.0102	CbGeAlD
Ondansetron—CYP3A7—endocrine gland—hypertension	0.000347	0.0102	CbGeAlD
Ondansetron—SLC47A1—kidney—hypertension	0.000344	0.0101	CbGeAlD
Ondansetron—SLC47A1—cortex of kidney—hypertension	0.000335	0.00986	CbGeAlD
Ondansetron—KCNH2—myocardium—hypertension	0.000327	0.00964	CbGeAlD
Ondansetron—SLC47A1—medulla oblongata—hypertension	0.0003	0.00884	CbGeAlD
Ondansetron—HTR1B—cardiovascular system—hypertension	0.0003	0.00883	CbGeAlD
Ondansetron—HTR1A—brainstem—hypertension	0.000297	0.00874	CbGeAlD
Ondansetron—SLC47A1—adrenal gland—hypertension	0.000278	0.00818	CbGeAlD
Ondansetron—HTR1A—cardiovascular system—hypertension	0.000242	0.00713	CbGeAlD
Ondansetron—SLC47A1—endocrine gland—hypertension	0.000241	0.0071	CbGeAlD
Ondansetron—KCNH2—heart—hypertension	0.000229	0.00673	CbGeAlD
Ondansetron—OPRM1—endocrine gland—hypertension	0.000225	0.00662	CbGeAlD
Ondansetron—HTR3A—central nervous system—hypertension	0.000221	0.00651	CbGeAlD
Ondansetron—SLC47A1—central nervous system—hypertension	0.000217	0.00639	CbGeAlD
Ondansetron—KCNH2—cardiovascular system—hypertension	0.000216	0.00635	CbGeAlD
Ondansetron—HTR1B—endocrine gland—hypertension	0.000206	0.00606	CbGeAlD
Ondansetron—OPRM1—central nervous system—hypertension	0.000203	0.00597	CbGeAlD
Ondansetron—CYP3A5—nephron tubule—hypertension	0.000198	0.00584	CbGeAlD
Ondansetron—KCNH2—cardiac atrium—hypertension	0.000195	0.00575	CbGeAlD
Ondansetron—HTR1A—adrenal gland—hypertension	0.000192	0.00564	CbGeAlD
Ondansetron—CYP2C9—heart—hypertension	0.000186	0.00547	CbGeAlD
Ondansetron—HTR1B—central nervous system—hypertension	0.000186	0.00546	CbGeAlD
Ondansetron—CYP2E1—nephron tubule—hypertension	0.000185	0.00544	CbGeAlD
Ondansetron—KCNH2—medulla oblongata—hypertension	0.000184	0.00542	CbGeAlD
Ondansetron—CYP2C9—cardiovascular system—hypertension	0.000175	0.00516	CbGeAlD
Ondansetron—CYP3A5—kidney—hypertension	0.000174	0.00513	CbGeAlD
Ondansetron—KCNH2—adrenal gland—hypertension	0.000171	0.00502	CbGeAlD
Ondansetron—CYP3A5—cortex of kidney—hypertension	0.00017	0.00499	CbGeAlD
Ondansetron—HTR1A—endocrine gland—hypertension	0.000166	0.00489	CbGeAlD
Ondansetron—CYP2E1—cardiovascular system—hypertension	0.000166	0.00489	CbGeAlD
Ondansetron—CYP2E1—kidney—hypertension	0.000163	0.00478	CbGeAlD
Ondansetron—CYP2D6—brainstem—hypertension	0.000161	0.00474	CbGeAlD
Ondansetron—CYP2E1—cortex of kidney—hypertension	0.000158	0.00466	CbGeAlD
Ondansetron—HTR1A—central nervous system—hypertension	0.00015	0.00441	CbGeAlD
Ondansetron—KCNH2—endocrine gland—hypertension	0.000148	0.00435	CbGeAlD
Ondansetron—CYP2E1—medulla oblongata—hypertension	0.000142	0.00418	CbGeAlD
Ondansetron—KCNH2—central nervous system—hypertension	0.000133	0.00392	CbGeAlD
Ondansetron—CYP2E1—adrenal gland—hypertension	0.000131	0.00387	CbGeAlD
Ondansetron—CYP3A4—kidney—hypertension	0.000131	0.00385	CbGeAlD
Ondansetron—CYP2D6—kidney—hypertension	0.000129	0.00379	CbGeAlD
Ondansetron—CYP1A2—endocrine gland—hypertension	0.000127	0.00373	CbGeAlD
Ondansetron—CYP3A5—endocrine gland—hypertension	0.000122	0.00359	CbGeAlD
Ondansetron—CYP2C9—endocrine gland—hypertension	0.00012	0.00354	CbGeAlD
Ondansetron—CYP2E1—endocrine gland—hypertension	0.000114	0.00335	CbGeAlD
Ondansetron—CYP2E1—central nervous system—hypertension	0.000103	0.00302	CbGeAlD
Ondansetron—CYP3A4—endocrine gland—hypertension	9.17e-05	0.0027	CbGeAlD
Ondansetron—CYP2D6—endocrine gland—hypertension	9.02e-05	0.00265	CbGeAlD
Ondansetron—CYP3A4—central nervous system—hypertension	8.26e-05	0.00243	CbGeAlD
Ondansetron—CYP2D6—central nervous system—hypertension	8.13e-05	0.00239	CbGeAlD
Ondansetron—Vomiting—Doxazosin—hypertension	2.5e-05	0.000159	CcSEcCtD
Ondansetron—Gastrointestinal pain—Irbesartan—hypertension	2.5e-05	0.000159	CcSEcCtD
Ondansetron—Feeling abnormal—Hydrochlorothiazide—hypertension	2.5e-05	0.000159	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	2.5e-05	0.000159	CcSEcCtD
Ondansetron—Hypersensitivity—Clonidine—hypertension	2.5e-05	0.000159	CcSEcCtD
Ondansetron—Body temperature increased—Captopril—hypertension	2.5e-05	0.000159	CcSEcCtD
Ondansetron—Abdominal pain—Captopril—hypertension	2.5e-05	0.000159	CcSEcCtD
Ondansetron—Headache—Carvedilol—hypertension	2.49e-05	0.000159	CcSEcCtD
Ondansetron—Discomfort—Timolol—hypertension	2.48e-05	0.000158	CcSEcCtD
Ondansetron—Rash—Doxazosin—hypertension	2.48e-05	0.000158	CcSEcCtD
Ondansetron—Fatigue—Losartan—hypertension	2.48e-05	0.000158	CcSEcCtD
Ondansetron—Dermatitis—Doxazosin—hypertension	2.48e-05	0.000158	CcSEcCtD
Ondansetron—Gastrointestinal pain—Hydrochlorothiazide—hypertension	2.48e-05	0.000158	CcSEcCtD
Ondansetron—Vomiting—Fosinopril—hypertension	2.47e-05	0.000157	CcSEcCtD
Ondansetron—Malaise—Lisinopril—hypertension	2.47e-05	0.000157	CcSEcCtD
Ondansetron—Anaphylactic shock—Ramipril—hypertension	2.47e-05	0.000157	CcSEcCtD
Ondansetron—Headache—Doxazosin—hypertension	2.47e-05	0.000157	CcSEcCtD
Ondansetron—Dry mouth—Timolol—hypertension	2.46e-05	0.000156	CcSEcCtD
Ondansetron—Pain—Losartan—hypertension	2.46e-05	0.000156	CcSEcCtD
Ondansetron—Constipation—Losartan—hypertension	2.46e-05	0.000156	CcSEcCtD
Ondansetron—Syncope—Lisinopril—hypertension	2.46e-05	0.000156	CcSEcCtD
Ondansetron—Vomiting—Eplerenone—hypertension	2.46e-05	0.000156	CcSEcCtD
Ondansetron—Feeling abnormal—Furosemide—hypertension	2.46e-05	0.000156	CcSEcCtD
Ondansetron—Rash—Fosinopril—hypertension	2.45e-05	0.000156	CcSEcCtD
Ondansetron—Dermatitis—Fosinopril—hypertension	2.45e-05	0.000156	CcSEcCtD
Ondansetron—Vomiting—Nifedipine—hypertension	2.44e-05	0.000155	CcSEcCtD
Ondansetron—Gastrointestinal pain—Furosemide—hypertension	2.44e-05	0.000155	CcSEcCtD
Ondansetron—Rash—Eplerenone—hypertension	2.44e-05	0.000155	CcSEcCtD
Ondansetron—Urticaria—Perindopril—hypertension	2.44e-05	0.000155	CcSEcCtD
Ondansetron—Headache—Fosinopril—hypertension	2.43e-05	0.000155	CcSEcCtD
Ondansetron—Hypersensitivity—Trandolapril—hypertension	2.43e-05	0.000155	CcSEcCtD
Ondansetron—Dermatitis—Eplerenone—hypertension	2.43e-05	0.000155	CcSEcCtD
Ondansetron—Diarrhoea—Valsartan—hypertension	2.43e-05	0.000155	CcSEcCtD
Ondansetron—Asthenia—Clonidine—hypertension	2.43e-05	0.000155	CcSEcCtD
Ondansetron—Feeling abnormal—Betaxolol—hypertension	2.43e-05	0.000155	CcSEcCtD
Ondansetron—Vomiting—Verapamil—hypertension	2.43e-05	0.000154	CcSEcCtD
Ondansetron—Urticaria—Irbesartan—hypertension	2.43e-05	0.000154	CcSEcCtD
Ondansetron—Shock—Ramipril—hypertension	2.43e-05	0.000154	CcSEcCtD
Ondansetron—Hypersensitivity—Enalapril—hypertension	2.43e-05	0.000154	CcSEcCtD
Ondansetron—Body temperature increased—Perindopril—hypertension	2.42e-05	0.000154	CcSEcCtD
Ondansetron—Abdominal pain—Perindopril—hypertension	2.42e-05	0.000154	CcSEcCtD
Ondansetron—Palpitations—Lisinopril—hypertension	2.42e-05	0.000154	CcSEcCtD
Ondansetron—Diarrhoea—Olmesartan—hypertension	2.42e-05	0.000154	CcSEcCtD
Ondansetron—Headache—Eplerenone—hypertension	2.42e-05	0.000154	CcSEcCtD
Ondansetron—Rash—Nifedipine—hypertension	2.42e-05	0.000154	CcSEcCtD
Ondansetron—Nervous system disorder—Ramipril—hypertension	2.42e-05	0.000154	CcSEcCtD
Ondansetron—Dermatitis—Nifedipine—hypertension	2.42e-05	0.000154	CcSEcCtD
Ondansetron—Body temperature increased—Irbesartan—hypertension	2.42e-05	0.000154	CcSEcCtD
Ondansetron—Abdominal pain—Irbesartan—hypertension	2.42e-05	0.000154	CcSEcCtD
Ondansetron—Anaphylactic shock—Timolol—hypertension	2.41e-05	0.000153	CcSEcCtD
Ondansetron—Loss of consciousness—Lisinopril—hypertension	2.41e-05	0.000153	CcSEcCtD
Ondansetron—Rash—Verapamil—hypertension	2.41e-05	0.000153	CcSEcCtD
Ondansetron—Urticaria—Hydrochlorothiazide—hypertension	2.41e-05	0.000153	CcSEcCtD
Ondansetron—Tachycardia—Ramipril—hypertension	2.41e-05	0.000153	CcSEcCtD
Ondansetron—Dermatitis—Verapamil—hypertension	2.41e-05	0.000153	CcSEcCtD
Ondansetron—Headache—Nifedipine—hypertension	2.4e-05	0.000153	CcSEcCtD
Ondansetron—Pruritus—Clonidine—hypertension	2.4e-05	0.000153	CcSEcCtD
Ondansetron—Abdominal pain—Hydrochlorothiazide—hypertension	2.4e-05	0.000152	CcSEcCtD
Ondansetron—Body temperature increased—Hydrochlorothiazide—hypertension	2.4e-05	0.000152	CcSEcCtD
Ondansetron—Skin disorder—Ramipril—hypertension	2.39e-05	0.000152	CcSEcCtD
Ondansetron—Headache—Verapamil—hypertension	2.39e-05	0.000152	CcSEcCtD
Ondansetron—Hypersensitivity—Telmisartan—hypertension	2.39e-05	0.000152	CcSEcCtD
Ondansetron—Cough—Lisinopril—hypertension	2.39e-05	0.000152	CcSEcCtD
Ondansetron—Asthenia—Trandolapril—hypertension	2.37e-05	0.000151	CcSEcCtD
Ondansetron—Shock—Timolol—hypertension	2.37e-05	0.000151	CcSEcCtD
Ondansetron—Feeling abnormal—Losartan—hypertension	2.37e-05	0.000151	CcSEcCtD
Ondansetron—Urticaria—Furosemide—hypertension	2.37e-05	0.000151	CcSEcCtD
Ondansetron—Nervous system disorder—Timolol—hypertension	2.36e-05	0.00015	CcSEcCtD
Ondansetron—Asthenia—Enalapril—hypertension	2.36e-05	0.00015	CcSEcCtD
Ondansetron—Body temperature increased—Furosemide—hypertension	2.36e-05	0.00015	CcSEcCtD
Ondansetron—Abdominal pain—Furosemide—hypertension	2.36e-05	0.00015	CcSEcCtD
Ondansetron—Gastrointestinal pain—Losartan—hypertension	2.35e-05	0.00015	CcSEcCtD
Ondansetron—Dizziness—Valsartan—hypertension	2.35e-05	0.00015	CcSEcCtD
Ondansetron—Urticaria—Betaxolol—hypertension	2.34e-05	0.000149	CcSEcCtD
Ondansetron—Skin disorder—Timolol—hypertension	2.34e-05	0.000149	CcSEcCtD
Ondansetron—Dizziness—Olmesartan—hypertension	2.34e-05	0.000149	CcSEcCtD
Ondansetron—Pruritus—Trandolapril—hypertension	2.34e-05	0.000149	CcSEcCtD
Ondansetron—Chest pain—Lisinopril—hypertension	2.33e-05	0.000148	CcSEcCtD
Ondansetron—Body temperature increased—Betaxolol—hypertension	2.33e-05	0.000148	CcSEcCtD
Ondansetron—Asthenia—Telmisartan—hypertension	2.33e-05	0.000148	CcSEcCtD
Ondansetron—Pruritus—Enalapril—hypertension	2.33e-05	0.000148	CcSEcCtD
Ondansetron—Anxiety—Lisinopril—hypertension	2.32e-05	0.000148	CcSEcCtD
Ondansetron—Diarrhoea—Clonidine—hypertension	2.32e-05	0.000148	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	2.32e-05	0.000147	CcSEcCtD
Ondansetron—Discomfort—Lisinopril—hypertension	2.3e-05	0.000147	CcSEcCtD
Ondansetron—Hypotension—Ramipril—hypertension	2.3e-05	0.000147	CcSEcCtD
Ondansetron—Pruritus—Telmisartan—hypertension	2.3e-05	0.000146	CcSEcCtD
Ondansetron—Urticaria—Losartan—hypertension	2.28e-05	0.000145	CcSEcCtD
Ondansetron—Dry mouth—Lisinopril—hypertension	2.28e-05	0.000145	CcSEcCtD
Ondansetron—Abdominal pain—Losartan—hypertension	2.27e-05	0.000145	CcSEcCtD
Ondansetron—Body temperature increased—Losartan—hypertension	2.27e-05	0.000145	CcSEcCtD
Ondansetron—Asthenia—Captopril—hypertension	2.27e-05	0.000144	CcSEcCtD
Ondansetron—Diarrhoea—Trandolapril—hypertension	2.26e-05	0.000144	CcSEcCtD
Ondansetron—Vomiting—Valsartan—hypertension	2.26e-05	0.000144	CcSEcCtD
Ondansetron—Diarrhoea—Enalapril—hypertension	2.25e-05	0.000143	CcSEcCtD
Ondansetron—Hypotension—Timolol—hypertension	2.25e-05	0.000143	CcSEcCtD
Ondansetron—Hypersensitivity—Irbesartan—hypertension	2.25e-05	0.000143	CcSEcCtD
Ondansetron—Vomiting—Olmesartan—hypertension	2.25e-05	0.000143	CcSEcCtD
Ondansetron—Rash—Valsartan—hypertension	2.24e-05	0.000143	CcSEcCtD
Ondansetron—Dizziness—Clonidine—hypertension	2.24e-05	0.000143	CcSEcCtD
Ondansetron—Dermatitis—Valsartan—hypertension	2.24e-05	0.000142	CcSEcCtD
Ondansetron—Anaphylactic shock—Lisinopril—hypertension	2.24e-05	0.000142	CcSEcCtD
Ondansetron—Pruritus—Captopril—hypertension	2.23e-05	0.000142	CcSEcCtD
Ondansetron—Hypersensitivity—Hydrochlorothiazide—hypertension	2.23e-05	0.000142	CcSEcCtD
Ondansetron—Rash—Olmesartan—hypertension	2.23e-05	0.000142	CcSEcCtD
Ondansetron—Dermatitis—Olmesartan—hypertension	2.23e-05	0.000142	CcSEcCtD
Ondansetron—Headache—Valsartan—hypertension	2.23e-05	0.000142	CcSEcCtD
Ondansetron—Diarrhoea—Telmisartan—hypertension	2.22e-05	0.000141	CcSEcCtD
Ondansetron—Headache—Olmesartan—hypertension	2.22e-05	0.000141	CcSEcCtD
Ondansetron—Paraesthesia—Ramipril—hypertension	2.21e-05	0.000141	CcSEcCtD
Ondansetron—Shock—Lisinopril—hypertension	2.2e-05	0.00014	CcSEcCtD
Ondansetron—Asthenia—Perindopril—hypertension	2.2e-05	0.00014	CcSEcCtD
Ondansetron—Dyspnoea—Ramipril—hypertension	2.2e-05	0.00014	CcSEcCtD
Ondansetron—Hypersensitivity—Furosemide—hypertension	2.2e-05	0.00014	CcSEcCtD
Ondansetron—Asthenia—Irbesartan—hypertension	2.19e-05	0.000139	CcSEcCtD
Ondansetron—Somnolence—Ramipril—hypertension	2.19e-05	0.000139	CcSEcCtD
Ondansetron—Dizziness—Trandolapril—hypertension	2.19e-05	0.000139	CcSEcCtD
Ondansetron—Tachycardia—Lisinopril—hypertension	2.18e-05	0.000139	CcSEcCtD
Ondansetron—Dizziness—Enalapril—hypertension	2.18e-05	0.000138	CcSEcCtD
Ondansetron—Asthenia—Hydrochlorothiazide—hypertension	2.17e-05	0.000138	CcSEcCtD
Ondansetron—Hypersensitivity—Betaxolol—hypertension	2.17e-05	0.000138	CcSEcCtD
Ondansetron—Skin disorder—Lisinopril—hypertension	2.17e-05	0.000138	CcSEcCtD
Ondansetron—Pruritus—Perindopril—hypertension	2.17e-05	0.000138	CcSEcCtD
Ondansetron—Paraesthesia—Timolol—hypertension	2.16e-05	0.000138	CcSEcCtD
Ondansetron—Pruritus—Irbesartan—hypertension	2.16e-05	0.000138	CcSEcCtD
Ondansetron—Diarrhoea—Captopril—hypertension	2.16e-05	0.000137	CcSEcCtD
Ondansetron—Vomiting—Clonidine—hypertension	2.15e-05	0.000137	CcSEcCtD
Ondansetron—Dyspnoea—Timolol—hypertension	2.15e-05	0.000137	CcSEcCtD
Ondansetron—Dizziness—Telmisartan—hypertension	2.15e-05	0.000137	CcSEcCtD
Ondansetron—Pruritus—Hydrochlorothiazide—hypertension	2.14e-05	0.000136	CcSEcCtD
Ondansetron—Somnolence—Timolol—hypertension	2.14e-05	0.000136	CcSEcCtD
Ondansetron—Asthenia—Furosemide—hypertension	2.14e-05	0.000136	CcSEcCtD
Ondansetron—Rash—Clonidine—hypertension	2.14e-05	0.000136	CcSEcCtD
Ondansetron—Dermatitis—Clonidine—hypertension	2.13e-05	0.000136	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Ramipril—hypertension	2.13e-05	0.000135	CcSEcCtD
Ondansetron—Fatigue—Ramipril—hypertension	2.13e-05	0.000135	CcSEcCtD
Ondansetron—Headache—Clonidine—hypertension	2.12e-05	0.000135	CcSEcCtD
Ondansetron—Hypersensitivity—Losartan—hypertension	2.12e-05	0.000135	CcSEcCtD
Ondansetron—Asthenia—Betaxolol—hypertension	2.12e-05	0.000135	CcSEcCtD
Ondansetron—Pruritus—Furosemide—hypertension	2.11e-05	0.000134	CcSEcCtD
Ondansetron—Constipation—Ramipril—hypertension	2.11e-05	0.000134	CcSEcCtD
Ondansetron—Vomiting—Trandolapril—hypertension	2.1e-05	0.000134	CcSEcCtD
Ondansetron—Diarrhoea—Perindopril—hypertension	2.1e-05	0.000133	CcSEcCtD
Ondansetron—Vomiting—Enalapril—hypertension	2.09e-05	0.000133	CcSEcCtD
Ondansetron—Diarrhoea—Irbesartan—hypertension	2.09e-05	0.000133	CcSEcCtD
Ondansetron—Hypotension—Lisinopril—hypertension	2.09e-05	0.000133	CcSEcCtD
Ondansetron—Dizziness—Captopril—hypertension	2.09e-05	0.000133	CcSEcCtD
Ondansetron—Pruritus—Betaxolol—hypertension	2.09e-05	0.000133	CcSEcCtD
Ondansetron—Rash—Trandolapril—hypertension	2.08e-05	0.000133	CcSEcCtD
Ondansetron—Dermatitis—Trandolapril—hypertension	2.08e-05	0.000132	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Timolol—hypertension	2.08e-05	0.000132	CcSEcCtD
Ondansetron—Fatigue—Timolol—hypertension	2.08e-05	0.000132	CcSEcCtD
Ondansetron—Rash—Enalapril—hypertension	2.08e-05	0.000132	CcSEcCtD
Ondansetron—Dermatitis—Enalapril—hypertension	2.07e-05	0.000132	CcSEcCtD
Ondansetron—Diarrhoea—Hydrochlorothiazide—hypertension	2.07e-05	0.000132	CcSEcCtD
Ondansetron—Headache—Trandolapril—hypertension	2.07e-05	0.000132	CcSEcCtD
Ondansetron—Vomiting—Telmisartan—hypertension	2.06e-05	0.000131	CcSEcCtD
Ondansetron—Asthenia—Losartan—hypertension	2.06e-05	0.000131	CcSEcCtD
Ondansetron—Headache—Enalapril—hypertension	2.06e-05	0.000131	CcSEcCtD
Ondansetron—Pain—Timolol—hypertension	2.06e-05	0.000131	CcSEcCtD
Ondansetron—Rash—Telmisartan—hypertension	2.05e-05	0.00013	CcSEcCtD
Ondansetron—Dermatitis—Telmisartan—hypertension	2.05e-05	0.00013	CcSEcCtD
Ondansetron—Diarrhoea—Furosemide—hypertension	2.04e-05	0.00013	CcSEcCtD
Ondansetron—Pruritus—Losartan—hypertension	2.03e-05	0.000129	CcSEcCtD
Ondansetron—Headache—Telmisartan—hypertension	2.03e-05	0.000129	CcSEcCtD
Ondansetron—Feeling abnormal—Ramipril—hypertension	2.03e-05	0.000129	CcSEcCtD
Ondansetron—Dizziness—Perindopril—hypertension	2.03e-05	0.000129	CcSEcCtD
Ondansetron—Dizziness—Irbesartan—hypertension	2.02e-05	0.000129	CcSEcCtD
Ondansetron—Diarrhoea—Betaxolol—hypertension	2.02e-05	0.000128	CcSEcCtD
Ondansetron—Gastrointestinal pain—Ramipril—hypertension	2.02e-05	0.000128	CcSEcCtD
Ondansetron—Paraesthesia—Lisinopril—hypertension	2.01e-05	0.000128	CcSEcCtD
Ondansetron—Vomiting—Captopril—hypertension	2.01e-05	0.000128	CcSEcCtD
Ondansetron—Dizziness—Hydrochlorothiazide—hypertension	2e-05	0.000127	CcSEcCtD
Ondansetron—Dyspnoea—Lisinopril—hypertension	1.99e-05	0.000127	CcSEcCtD
Ondansetron—Rash—Captopril—hypertension	1.99e-05	0.000127	CcSEcCtD
Ondansetron—Dermatitis—Captopril—hypertension	1.99e-05	0.000127	CcSEcCtD
Ondansetron—Somnolence—Lisinopril—hypertension	1.99e-05	0.000126	CcSEcCtD
Ondansetron—Feeling abnormal—Timolol—hypertension	1.99e-05	0.000126	CcSEcCtD
Ondansetron—Headache—Captopril—hypertension	1.98e-05	0.000126	CcSEcCtD
Ondansetron—Gastrointestinal pain—Timolol—hypertension	1.97e-05	0.000125	CcSEcCtD
Ondansetron—Dizziness—Furosemide—hypertension	1.97e-05	0.000125	CcSEcCtD
Ondansetron—Diarrhoea—Losartan—hypertension	1.97e-05	0.000125	CcSEcCtD
Ondansetron—Urticaria—Ramipril—hypertension	1.96e-05	0.000125	CcSEcCtD
Ondansetron—Dizziness—Betaxolol—hypertension	1.95e-05	0.000124	CcSEcCtD
Ondansetron—Vomiting—Perindopril—hypertension	1.95e-05	0.000124	CcSEcCtD
Ondansetron—Abdominal pain—Ramipril—hypertension	1.95e-05	0.000124	CcSEcCtD
Ondansetron—Body temperature increased—Ramipril—hypertension	1.95e-05	0.000124	CcSEcCtD
Ondansetron—Vomiting—Irbesartan—hypertension	1.94e-05	0.000124	CcSEcCtD
Ondansetron—Rash—Perindopril—hypertension	1.93e-05	0.000123	CcSEcCtD
Ondansetron—Dermatitis—Perindopril—hypertension	1.93e-05	0.000123	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Lisinopril—hypertension	1.93e-05	0.000123	CcSEcCtD
Ondansetron—Fatigue—Lisinopril—hypertension	1.93e-05	0.000123	CcSEcCtD
Ondansetron—Vomiting—Hydrochlorothiazide—hypertension	1.93e-05	0.000123	CcSEcCtD
Ondansetron—Rash—Irbesartan—hypertension	1.93e-05	0.000123	CcSEcCtD
Ondansetron—Dermatitis—Irbesartan—hypertension	1.92e-05	0.000122	CcSEcCtD
Ondansetron—Headache—Perindopril—hypertension	1.92e-05	0.000122	CcSEcCtD
Ondansetron—Urticaria—Timolol—hypertension	1.91e-05	0.000122	CcSEcCtD
Ondansetron—Headache—Irbesartan—hypertension	1.91e-05	0.000122	CcSEcCtD
Ondansetron—Pain—Lisinopril—hypertension	1.91e-05	0.000122	CcSEcCtD
Ondansetron—Constipation—Lisinopril—hypertension	1.91e-05	0.000122	CcSEcCtD
Ondansetron—Rash—Hydrochlorothiazide—hypertension	1.91e-05	0.000122	CcSEcCtD
Ondansetron—Dermatitis—Hydrochlorothiazide—hypertension	1.91e-05	0.000121	CcSEcCtD
Ondansetron—Abdominal pain—Timolol—hypertension	1.91e-05	0.000121	CcSEcCtD
Ondansetron—Body temperature increased—Timolol—hypertension	1.91e-05	0.000121	CcSEcCtD
Ondansetron—Dizziness—Losartan—hypertension	1.9e-05	0.000121	CcSEcCtD
Ondansetron—Headache—Hydrochlorothiazide—hypertension	1.9e-05	0.000121	CcSEcCtD
Ondansetron—Vomiting—Furosemide—hypertension	1.89e-05	0.000121	CcSEcCtD
Ondansetron—Rash—Furosemide—hypertension	1.88e-05	0.00012	CcSEcCtD
Ondansetron—Dermatitis—Furosemide—hypertension	1.88e-05	0.000119	CcSEcCtD
Ondansetron—Vomiting—Betaxolol—hypertension	1.88e-05	0.000119	CcSEcCtD
Ondansetron—Headache—Furosemide—hypertension	1.87e-05	0.000119	CcSEcCtD
Ondansetron—Rash—Betaxolol—hypertension	1.86e-05	0.000118	CcSEcCtD
Ondansetron—Dermatitis—Betaxolol—hypertension	1.86e-05	0.000118	CcSEcCtD
Ondansetron—Headache—Betaxolol—hypertension	1.85e-05	0.000118	CcSEcCtD
Ondansetron—Feeling abnormal—Lisinopril—hypertension	1.84e-05	0.000117	CcSEcCtD
Ondansetron—Gastrointestinal pain—Lisinopril—hypertension	1.83e-05	0.000116	CcSEcCtD
Ondansetron—Vomiting—Losartan—hypertension	1.83e-05	0.000116	CcSEcCtD
Ondansetron—Hypersensitivity—Ramipril—hypertension	1.82e-05	0.000116	CcSEcCtD
Ondansetron—Rash—Losartan—hypertension	1.81e-05	0.000115	CcSEcCtD
Ondansetron—Dermatitis—Losartan—hypertension	1.81e-05	0.000115	CcSEcCtD
Ondansetron—Headache—Losartan—hypertension	1.8e-05	0.000115	CcSEcCtD
Ondansetron—Urticaria—Lisinopril—hypertension	1.78e-05	0.000113	CcSEcCtD
Ondansetron—Hypersensitivity—Timolol—hypertension	1.78e-05	0.000113	CcSEcCtD
Ondansetron—Asthenia—Ramipril—hypertension	1.77e-05	0.000113	CcSEcCtD
Ondansetron—Abdominal pain—Lisinopril—hypertension	1.77e-05	0.000112	CcSEcCtD
Ondansetron—Body temperature increased—Lisinopril—hypertension	1.77e-05	0.000112	CcSEcCtD
Ondansetron—Pruritus—Ramipril—hypertension	1.74e-05	0.000111	CcSEcCtD
Ondansetron—Asthenia—Timolol—hypertension	1.73e-05	0.00011	CcSEcCtD
Ondansetron—Pruritus—Timolol—hypertension	1.71e-05	0.000108	CcSEcCtD
Ondansetron—Diarrhoea—Ramipril—hypertension	1.69e-05	0.000107	CcSEcCtD
Ondansetron—Diarrhoea—Timolol—hypertension	1.65e-05	0.000105	CcSEcCtD
Ondansetron—Hypersensitivity—Lisinopril—hypertension	1.65e-05	0.000105	CcSEcCtD
Ondansetron—Dizziness—Ramipril—hypertension	1.63e-05	0.000104	CcSEcCtD
Ondansetron—Asthenia—Lisinopril—hypertension	1.6e-05	0.000102	CcSEcCtD
Ondansetron—Dizziness—Timolol—hypertension	1.59e-05	0.000101	CcSEcCtD
Ondansetron—Pruritus—Lisinopril—hypertension	1.58e-05	0.000101	CcSEcCtD
Ondansetron—Vomiting—Ramipril—hypertension	1.57e-05	9.97e-05	CcSEcCtD
Ondansetron—Rash—Ramipril—hypertension	1.55e-05	9.89e-05	CcSEcCtD
Ondansetron—Dermatitis—Ramipril—hypertension	1.55e-05	9.88e-05	CcSEcCtD
Ondansetron—Headache—Ramipril—hypertension	1.54e-05	9.83e-05	CcSEcCtD
Ondansetron—Vomiting—Timolol—hypertension	1.53e-05	9.75e-05	CcSEcCtD
Ondansetron—Diarrhoea—Lisinopril—hypertension	1.53e-05	9.73e-05	CcSEcCtD
Ondansetron—Rash—Timolol—hypertension	1.52e-05	9.67e-05	CcSEcCtD
Ondansetron—Dermatitis—Timolol—hypertension	1.52e-05	9.66e-05	CcSEcCtD
Ondansetron—Headache—Timolol—hypertension	1.51e-05	9.61e-05	CcSEcCtD
Ondansetron—Dizziness—Lisinopril—hypertension	1.48e-05	9.41e-05	CcSEcCtD
Ondansetron—Vomiting—Lisinopril—hypertension	1.42e-05	9.05e-05	CcSEcCtD
Ondansetron—Rash—Lisinopril—hypertension	1.41e-05	8.97e-05	CcSEcCtD
Ondansetron—Dermatitis—Lisinopril—hypertension	1.41e-05	8.96e-05	CcSEcCtD
Ondansetron—Headache—Lisinopril—hypertension	1.4e-05	8.91e-05	CcSEcCtD
Ondansetron—HTR1A—Signaling Pathways—POMC—hypertension	1.25e-06	1.28e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CAV1—hypertension	1.25e-06	1.27e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—INS—hypertension	1.25e-06	1.27e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CAV1—hypertension	1.24e-06	1.27e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—APOA1—hypertension	1.24e-06	1.27e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—APOA1—hypertension	1.24e-06	1.27e-05	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—AKT1—hypertension	1.23e-06	1.26e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCL2—hypertension	1.23e-06	1.25e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—IL6—hypertension	1.21e-06	1.24e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IGF1—hypertension	1.2e-06	1.23e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—AKT2—hypertension	1.2e-06	1.23e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—EGFR—hypertension	1.2e-06	1.22e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—RELA—hypertension	1.19e-06	1.22e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PTGS2—hypertension	1.19e-06	1.22e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hypertension	1.19e-06	1.21e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—COMT—hypertension	1.19e-06	1.21e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—TH—hypertension	1.18e-06	1.21e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CALM2—hypertension	1.18e-06	1.2e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—COMT—hypertension	1.18e-06	1.2e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ALDH2—hypertension	1.17e-06	1.2e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PPARGC1A—hypertension	1.17e-06	1.2e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GNB3—hypertension	1.17e-06	1.2e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MTOR—hypertension	1.17e-06	1.19e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—HMOX1—hypertension	1.16e-06	1.19e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—hypertension	1.16e-06	1.19e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PPARGC1A—hypertension	1.16e-06	1.19e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GNB3—hypertension	1.16e-06	1.19e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—HMOX1—hypertension	1.15e-06	1.18e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MMP9—hypertension	1.15e-06	1.18e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—SLC2A4—hypertension	1.15e-06	1.17e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GCG—hypertension	1.15e-06	1.17e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CAT—hypertension	1.15e-06	1.17e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CDKN1A—hypertension	1.15e-06	1.17e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SERPINE1—hypertension	1.14e-06	1.17e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PTEN—hypertension	1.14e-06	1.17e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—HBA1—hypertension	1.14e-06	1.17e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CAT—hypertension	1.14e-06	1.16e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GNAS—hypertension	1.14e-06	1.16e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP11A1—hypertension	1.13e-06	1.16e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hypertension	1.13e-06	1.16e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GNAS—hypertension	1.13e-06	1.15e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CXCL8—hypertension	1.12e-06	1.15e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MAPK8—hypertension	1.12e-06	1.14e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—AKT1—hypertension	1.12e-06	1.14e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—APOB—hypertension	1.12e-06	1.14e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GSTT1—hypertension	1.11e-06	1.14e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SLC9A1—hypertension	1.11e-06	1.14e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GOT1—hypertension	1.11e-06	1.14e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—FGF2—hypertension	1.11e-06	1.13e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—APOB—hypertension	1.11e-06	1.13e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—RHOA—hypertension	1.1e-06	1.13e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CETP—hypertension	1.1e-06	1.12e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GCLC—hypertension	1.1e-06	1.12e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PPARG—hypertension	1.1e-06	1.12e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PPARG—hypertension	1.09e-06	1.12e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PIK3R1—hypertension	1.09e-06	1.12e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NOS3—hypertension	1.09e-06	1.12e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—EP300—hypertension	1.09e-06	1.11e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GSTM1—hypertension	1.09e-06	1.11e-05	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—AKT1—hypertension	1.08e-06	1.11e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—STK11—hypertension	1.08e-06	1.1e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP19A1—hypertension	1.08e-06	1.1e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—POMC—hypertension	1.08e-06	1.1e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—POMC—hypertension	1.08e-06	1.1e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GSTM1—hypertension	1.08e-06	1.1e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—INS—hypertension	1.08e-06	1.1e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—INS—hypertension	1.07e-06	1.1e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—IL6—hypertension	1.07e-06	1.09e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—LPL—hypertension	1.07e-06	1.09e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—SRC—hypertension	1.06e-06	1.08e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—LPL—hypertension	1.06e-06	1.08e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP17A1—hypertension	1.05e-06	1.08e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ENO1—hypertension	1.04e-06	1.07e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PTGS1—hypertension	1.04e-06	1.07e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ADCY5—hypertension	1.04e-06	1.07e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GPX1—hypertension	1.04e-06	1.06e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PTEN—hypertension	1.04e-06	1.06e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ADCY5—hypertension	1.03e-06	1.06e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—VEGFA—hypertension	1.03e-06	1.06e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GPX1—hypertension	1.03e-06	1.05e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CYP1A1—hypertension	1.03e-06	1.05e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PRKCA—hypertension	1.03e-06	1.05e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—RELA—hypertension	1.03e-06	1.05e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PRKCA—hypertension	1.02e-06	1.04e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CYP1A1—hypertension	1.02e-06	1.04e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MMP9—hypertension	1.02e-06	1.04e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hypertension	1.02e-06	1.04e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CD36—hypertension	1.01e-06	1.03e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CDKN1A—hypertension	1.01e-06	1.03e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PTEN—hypertension	1.01e-06	1.03e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MTOR—hypertension	1.01e-06	1.03e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—COMT—hypertension	1.01e-06	1.03e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CTGF—hypertension	1e-06	1.03e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CD36—hypertension	1e-06	1.03e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—HMGCR—hypertension	9.96e-07	1.02e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GOT2—hypertension	9.96e-07	1.02e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GNB3—hypertension	9.91e-07	1.01e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PPARGC1A—hypertension	9.91e-07	1.01e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—EP300—hypertension	9.9e-07	1.01e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MAPK8—hypertension	9.87e-07	1.01e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—HMOX1—hypertension	9.87e-07	1.01e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ALB—hypertension	9.86e-07	1.01e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—AKT1—hypertension	9.85e-07	1.01e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ALB—hypertension	9.84e-07	1e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ADRA2A—hypertension	9.75e-07	9.96e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CAT—hypertension	9.74e-07	9.95e-06	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CXCL8—hypertension	9.69e-07	9.9e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hypertension	9.68e-07	9.89e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GNAS—hypertension	9.65e-07	9.86e-06	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—EP300—hypertension	9.63e-07	9.83e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—MTHFR—hypertension	9.59e-07	9.8e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—MTHFR—hypertension	9.51e-07	9.71e-06	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MYC—hypertension	9.5e-07	9.71e-06	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TGFB1—hypertension	9.48e-07	9.69e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—APOB—hypertension	9.45e-07	9.66e-06	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PIK3R1—hypertension	9.43e-07	9.63e-06	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—NOS3—hypertension	9.43e-07	9.63e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PPARA—hypertension	9.41e-07	9.61e-06	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—NOS3—hypertension	9.41e-07	9.61e-06	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PIK3R1—hypertension	9.41e-07	9.61e-06	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SRC—hypertension	9.36e-07	9.56e-06	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—AKT1—hypertension	9.36e-07	9.56e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PPARA—hypertension	9.33e-07	9.53e-06	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—EGFR—hypertension	9.3e-07	9.5e-06	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—IL6—hypertension	9.21e-07	9.41e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GSTM1—hypertension	9.2e-07	9.39e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—TH—hypertension	9.13e-07	9.32e-06	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—VEGFA—hypertension	9.12e-07	9.31e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—AGT—hypertension	9.11e-07	9.31e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CALM2—hypertension	9.09e-07	9.29e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—AGT—hypertension	9.04e-07	9.23e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—LPL—hypertension	9.03e-07	9.22e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CALM1—hypertension	8.96e-07	9.16e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—APOE—hypertension	8.93e-07	9.12e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CALM1—hypertension	8.88e-07	9.08e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GCG—hypertension	8.88e-07	9.07e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SLC2A4—hypertension	8.88e-07	9.07e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—APOE—hypertension	8.85e-07	9.04e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CAV1—hypertension	8.85e-07	9.04e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ADCY5—hypertension	8.84e-07	9.03e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—APOA1—hypertension	8.83e-07	9.02e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GPX1—hypertension	8.81e-07	9e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CAV1—hypertension	8.77e-07	8.96e-06	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MMP9—hypertension	8.76e-07	8.95e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—APOA1—hypertension	8.75e-07	8.94e-06	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CDKN1A—hypertension	8.73e-07	8.92e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PRKCA—hypertension	8.72e-07	8.9e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP1A1—hypertension	8.72e-07	8.9e-06	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PTEN—hypertension	8.71e-07	8.9e-06	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PTGS2—hypertension	8.62e-07	8.81e-06	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PTGS2—hypertension	8.61e-07	8.79e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GOT1—hypertension	8.6e-07	8.78e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CD36—hypertension	8.58e-07	8.76e-06	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MAPK8—hypertension	8.52e-07	8.71e-06	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—AKT1—hypertension	8.5e-07	8.68e-06	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MYC—hypertension	8.39e-07	8.57e-06	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TGFB1—hypertension	8.37e-07	8.55e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—STK11—hypertension	8.35e-07	8.53e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP19A1—hypertension	8.35e-07	8.53e-06	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—EP300—hypertension	8.31e-07	8.49e-06	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—EGFR—hypertension	8.2e-07	8.38e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—MTHFR—hypertension	8.13e-07	8.3e-06	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SRC—hypertension	8.08e-07	8.25e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PPARA—hypertension	7.97e-07	8.14e-06	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—VEGFA—hypertension	7.87e-07	8.04e-06	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TP53—hypertension	7.81e-07	7.97e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PPARG—hypertension	7.78e-07	7.95e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—COMT—hypertension	7.76e-07	7.93e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—AGT—hypertension	7.72e-07	7.89e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PPARG—hypertension	7.71e-07	7.88e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—POMC—hypertension	7.67e-07	7.84e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PPARGC1A—hypertension	7.65e-07	7.82e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GNB3—hypertension	7.65e-07	7.82e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—INS—hypertension	7.63e-07	7.79e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—HMOX1—hypertension	7.62e-07	7.78e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—POMC—hypertension	7.61e-07	7.77e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CALM1—hypertension	7.59e-07	7.76e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—APOE—hypertension	7.57e-07	7.73e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—INS—hypertension	7.56e-07	7.73e-06	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PTEN—hypertension	7.52e-07	7.68e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CAT—hypertension	7.51e-07	7.68e-06	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PTEN—hypertension	7.5e-07	7.67e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CAV1—hypertension	7.5e-07	7.66e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—APOA1—hypertension	7.48e-07	7.64e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GNAS—hypertension	7.45e-07	7.61e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—APOB—hypertension	7.3e-07	7.45e-06	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MYC—hypertension	7.24e-07	7.4e-06	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TGFB1—hypertension	7.22e-07	7.38e-06	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—EP300—hypertension	7.17e-07	7.33e-06	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—EP300—hypertension	7.16e-07	7.31e-06	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL6—hypertension	7.14e-07	7.3e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GSTM1—hypertension	7.1e-07	7.25e-06	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—EGFR—hypertension	7.08e-07	7.23e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ALB—hypertension	6.99e-07	7.15e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—LPL—hypertension	6.97e-07	7.12e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ALB—hypertension	6.93e-07	7.08e-06	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TP53—hypertension	6.89e-07	7.04e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ADCY5—hypertension	6.82e-07	6.97e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GPX1—hypertension	6.8e-07	6.94e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PRKCA—hypertension	6.73e-07	6.87e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP1A1—hypertension	6.73e-07	6.87e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PIK3R1—hypertension	6.69e-07	6.83e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—NOS3—hypertension	6.69e-07	6.83e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PIK3R1—hypertension	6.63e-07	6.78e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—NOS3—hypertension	6.63e-07	6.78e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CD36—hypertension	6.62e-07	6.76e-06	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—AKT1—hypertension	6.59e-07	6.73e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PPARG—hypertension	6.59e-07	6.73e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—POMC—hypertension	6.5e-07	6.64e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—INS—hypertension	6.46e-07	6.6e-06	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL6—hypertension	6.31e-07	6.44e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—MTHFR—hypertension	6.27e-07	6.41e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PPARA—hypertension	6.15e-07	6.29e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PTGS2—hypertension	6.12e-07	6.25e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PTGS2—hypertension	6.07e-07	6.2e-06	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—AKT1—hypertension	5.98e-07	6.11e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—AGT—hypertension	5.96e-07	6.09e-06	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TP53—hypertension	5.95e-07	6.07e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ALB—hypertension	5.93e-07	6.05e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CALM1—hypertension	5.86e-07	5.99e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—APOE—hypertension	5.84e-07	5.96e-06	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—AKT1—hypertension	5.82e-07	5.94e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CAV1—hypertension	5.79e-07	5.91e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—APOA1—hypertension	5.77e-07	5.9e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—NOS3—hypertension	5.67e-07	5.79e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PIK3R1—hypertension	5.67e-07	5.79e-06	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL6—hypertension	5.44e-07	5.56e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PTEN—hypertension	5.34e-07	5.45e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PTEN—hypertension	5.29e-07	5.4e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PTGS2—hypertension	5.18e-07	5.3e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—EP300—hypertension	5.09e-07	5.2e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PPARG—hypertension	5.09e-07	5.2e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—EP300—hypertension	5.05e-07	5.15e-06	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—AKT1—hypertension	5.02e-07	5.13e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—POMC—hypertension	5.02e-07	5.12e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—INS—hypertension	4.99e-07	5.1e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ALB—hypertension	4.57e-07	4.67e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PTEN—hypertension	4.52e-07	4.62e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PIK3R1—hypertension	4.37e-07	4.47e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—NOS3—hypertension	4.37e-07	4.47e-06	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—AKT1—hypertension	4.33e-07	4.43e-06	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—AKT1—hypertension	4.33e-07	4.42e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—EP300—hypertension	4.31e-07	4.4e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PTGS2—hypertension	4e-07	4.09e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PTEN—hypertension	3.49e-07	3.56e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—EP300—hypertension	3.33e-07	3.4e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—AKT1—hypertension	3.08e-07	3.14e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—AKT1—hypertension	3.05e-07	3.11e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—AKT1—hypertension	2.61e-07	2.66e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—AKT1—hypertension	2.01e-07	2.05e-06	CbGpPWpGaD
